Sattva S. Neelapu, MD, from the University of Texas MD Anderson Cancer Center discusses how Axi-Cel is a milestone for treating B-Cell Lymphoma and the paradigm shift for future B-Cell Lymphoma treatment at the 2017 American Society of Hematology.
Axi-Cel is a milestone for treating B-Cell Lymphoma Paradigm shift for future B-Cell Lymphoma treatment
